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Background: Thorax is the common place to develop Castleman disease (CD), but there is no systemic clinical
analysis for intrathoracic CD.
Methods: We conducted a retrospective analysis of 48 intrathoracic CD patients with definite pathological
diagnosis who were hospitalized between 1992 and 2012 in a Chinese tertiary referral hospital.
Results: The study included 16 cases with unicentric CD (UCD) and 32 cases with multicentric CD (MCD). UCD
were younger than MCD (30.5y vs 41.6ys, P < 0.05). MCD were more symptomatic (50% vs 96.9%, P < 0.001) and
sicker than UCD, including more fever, hepatomegaly and/or splenomegaly and hypoalbuminemia. All of UCD
showed solitary mass in various sites and two of them were complicated by small pleural effusion. In the MCD
group, their chest CT showed obvious lymphadenopathy in the hilum and/or mediastinum (100%), diffuse
parenchymal lung shadows (43.75%), pleural effusion (40.6%), mass in the mediastinum (6.25%) or hilum (3.12%)
and bronchiolitis obliterans (BO) (3.12%). Besides LIP-like images, multiple nodules of different size and sites, patchy,
ground-glass opacities and consolidation were showed in their chest CT. Surgery were arranged for all UCD for
diagnosis and treatment and all were alive. In MCD group, superficial lymph nodes biopsies (21 cases), surgery
biopsy (9 cases) and CT-guided percutaneous lung biopsy (2 cases) were performed. Hyaline vascular (HV) variant
were more common in the UCD group (75% vs 37.5%, P < 0.05). In MCD group, 28 cases were prescribed with
chemotherapy, one refused to receive therapy and the rest three were arranged for regular follow-up. Among MCD,
18 cases was improved, 7 cases was stable, 4 cases lost follow-up and 3 cases died.
Conclusions: Intrathoracic MCD was more common than UCD in our hospital. MCD was older, more symptomic
and sicker than UCD. HV variant were more common in UCD. All of UCD showed mass in various intrathoracic
locations and surgery resection was performed for all and all were alive. Mass, pleural effusion, BO and diffuse pulmonary
shadows, including LIP-like images, multiple nodules of different size and sites, patchy, GGO and consolidations
were showed in our MCD. Most of MCD cases were arranged with chemotherapy and their prognosis were worse
than UCD’s.
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Castleman disease (CD) is also known as angiofollicular
hyperplasia or giant lymph node hyperplasia. It can be
classified as unicentric (unifocal or localized) or multi-
centric (multifocal or generalized) according to the le-
sions involved [1-3]. Although CD can occur at any site
where lymphoid tissue is normally present, approxi-
mately 70% of CD occurred in the thorax [4,5]. Intratho-
racic involvement of CD can manifest as a mediastinal
and/or hilar mass, pleural mass, tracheal mass, pleural
effusion, bronchiolitis obliterans, diffuse parenchymal
lung disease, etc. [6-16]. However, most of this data
comes from rare case reports or smaller case series. And
some of these included cases with the main focus of dis-
ease in the neck, supraclavicular and/or axillary nodes
[6]. Here we describe the clinical and radiological fin-
dings, as well as the outcomes of 48 intrathoracic CD
patients in a single Chinese tertiary-referral hospital.
Methods
Patients
Using a computer-assisted search for patients who were
hospitalized with CD at Peking Union Medical College
Hospital from January 1992 to December 2012, we iden-
tified 151 CD cases with the confirmed pathological
diagnosis. Patients with POEMS syndrome (polyneurop-
athy, organomegaly, endocrinopathy, M-protein, skin pig-
mentation) and without complete clinical or radiological
data (32 cases) were excluded even if they had the typical
pathological features of CD. After review of the medical
records, radiologic images and pathological manifesta-
tions, 48 intrathoracic CD cases were identified. All of the
patients had the main focus of disease inside the chest
cage, excluding those with their main involvements in the
neck, supraclavicular region, axillary nodes, heart, pericar-
dium and around the aorta. The remaining 71 cases were
classified as the extrathoracic CD group.
The following information was recorded for analysis:
age, sex, symptoms at presentation, physical examination,
and laboratory findings (including serological results, ra-
diologic findings, and pathological results), treatment and
outcomes. Patients’ computed tomography (CT) images
were downloaded from our hospital’s image data bank.
Two radiologists conducted a consensus reading of the
CT images. All of the cases with diffuse pulmonary disease
were admitted after 1998, so all of these patients had
high-resolution chest CT imaging. The biopsies from sec-
tions of involved tissues and/or organs were reviewed by
two pathologists in our pathological department (Ya lan Bi
and Rui e Feng). The pathological diagnosis of CD was
established according to Flendrig and Keller’s criteria in all
of the enrolled patients [17,18]. The hyaline vascular (HV)
variant is characterized by the presence of atrophic germi-
nal centers which are surrounded by expanded mantlezones of small lymphocytes forming concentric rings
(“Onion-skinning”), and hyalinized blood vessels penetra-
ting into follicles. For the plasma cell (PC) variant, there is
retained lymph node architecture and variable germinal
center hyperplasia, with expanded mantle zones and a
marked plasmacytosis in the mantle or paracortical re-
gions. Malignant lymphoma, granulomas and histiocytic
necrotizing lymphadnitis are excluded. Immunostaining
with CD3 and CD20 were performed for both HV and PC
variant, but immunostaining with CD38 and CD138 were
performed only for PC variant. The mixed variant displays
features of both HV and PC variant.
Other definitions in this study included : (1) anemia de-
fined as hemoglobin <110 g/l for female and <120 g/l for
male, (2) thrombocytopenia defined as PLT <100 × 109/L,
(3) hypoalbuminemia defined as serum albumin < 35 g/l,
(4) elevation of immunoglobin G(IgG) defined as serum
IgG > 17 g/L, and (5) elevation of lactate dehydrogenase
(LDH) defined as serum LDH >270 U/L.
All patient data were followed to September 2014.
Data was collected through telephone, letters and cases
records. All patients and/or their families provided writ-
ten informed consent to publish their clinical details.
The study was approved by the ethics committee of
Peking Union Medical College Hospital.
Statistical analysis
Data was analyzed using the Statistical Analysis System
(SAS) version 8.0 software package. Quantitative varia-
bles were described using mean ± SD and categorical
data using frequency and percentage in the text and fig-
ures. A comparison between two groups was analyzed
by the student’s t-test when data was normally distri-
buted. The Kruskal-Wallis test was used when data were
not normally distributed. A value of P < 0.05 was consi-
dered to be statistically significant.
Results
Human immunodeficiency virus (HIV) antibody scree-
ning test was arranged for 95 CD cases, including 42
intrathoracic cases, and all of them were negative. All
cases which were not screened for HIV antibodies were
admitted before 2000.
Demographic characteristics
The intrathoracic CD group consisted of 19 male and 29
female patients with a mean age of 37.9y (range between
13–67 years of age). Among them, 16cases (33.3%) were
classified with unicentric CD (UCD) and the remaining
32cases (66.7%) were diagnosed with muticentric CD
(MCD). As we know now that there were many diffe-
rences between the UCD and MCD in clinical, radio-
logical, pathological and prognostic features [1,19,20],
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our hospital (Table 1).
UCD patients were younger than MCD cases, with the
mean age of 30.5y and 41.6ys, respectively (t = 3.03,
P = 0.004). But there was no difference in the gender
distribution between them, with male cases of 50% vs
34.4%, respectively (χ2 = 1.09, P = 0.30) (Table 1).
Clinical and radiological manifestations
The clinical characteristics are summarized in Table 1.
Half of the UCD cases had no obvious symptoms when
they were admitted to our hospital, but were found to
have masses on a routine chest radiographic examination.Table 1 Differences between unicentric and multicentric
intrathoracic CD cases
UCD MCD P
Age (mean, years) 30.44 ± 8.00 41.56 ± 13.50 0.004
Gender
Male 8/50% 11/34.4% 0.2967
Female 8/50% 21/65.6%
Pathological type
Hyaline vascular 3/18.75% 16/50%
Plasma cell 12/75% 12/37.5% 0.049
Mixed 1/6.25% 4/12.5%
Non-symptomatic 8/50% 1/3.1% <0.001
Fever 0 16/50% <0.001




Anemia 3/18.8% 15/46.9% 0.0578
Hemoglobin (g/l) 133.13 ± 29.70 108.66 ± 26.60 0.0059
Platelet (×109/l)
>300 × 109/l 4/25% 12/37.5% 0.6785
<100 × 109/l 1/8.3% 2/10%
Hypoalbuminia 4/25% 22/68.8% 0.0041
Elevation of serum LDH‡ 5/30% 5/16.1% 0.6731
HIV-Ab
Not done 0 6/18.75%
Negative 16/100% 26/100% (n = 26) 1




Stable 0 7/21.9% <0.001
Died 0 3/9.4%
Lost follow-up 0 4/12.5%
‡Fifteen UCD cases and 31 MCD cases were detected with serum LDH.
LDH: lactate dehydrogenase, HIV: human immunodeficiency virus.Thirty-one out of 32 cases with MCD were symptomatic
(50% vs 96.9%, χ2 = 15.4, P < 0.001). Although fever was
the most common symptom for MCD cases (16/50%),
there were no patients with UCD presenting with fever
(0 vs 50%, χ2 = 11.4, P < 0.001). None of the patients with
UCD had hepatomegaly and/or splenomegaly, but half of
these cases in the MCD group had hepatomegaly and/or
splenomegaly (0 vs 50%, χ2 = 11.4, P < 0.001).
In the UCD group, 8 cases complained of at least one
of the following symptoms: dyspnea or chest distress
(4/25%), dry cough (3/18.75%), backache (1/6.25%) and
chest pain (1/625%). Although all cases had a solitary
mass in their contrast chest CT, they were distributed in
various sites: mediastinum (11 cases/68.75%), lung hilum
(3 cases/18.75%), intrapulmonary fissure (1 case/6.25%)
and in the lung (1 case/6.25%) (Figure 1). Punctate
calcification in the mass was showed in 5 UCD cases.
Fourteen cases had been arranged for the chest contrast-
enhanced CT, and two cases had been arranged for chest
magnetic resonance imaging (MRI). High to moderate
enhancement of the mass could be seen in the enhanced
CT. The mean size of the mass was 113.56 cm3 (ranged
from 20 cm3 to 336 cm3). Two of them were compli-
cated by small pleural effusions.
In the MCD group, 31cases suffered from at least
one of the following symptoms: fever (16/50%), cough
(15/46.88%), dyspnea (15/46.88%), fatigue (10/31.25%),
abdominal distention (6/18.75%), edema (6/18.75%) and
chest pain (1/3.12%). Only one patient had no obvious
symptoms.
All cases had significant abnormalities on their chest
CT (Table 2), including obvious lymphadenopathy in the
hilum and/or mediastinum (32/100%), diffuse parenchy-
mal lung disease (14/43.75%), pleural effusion (13/40.6%),
mass in the mediastinum (2/6.25%) or hilum (1/3.12%)
and bronchiolitis obliterans (BO) (1/3.12%). Thoracentesis
was performed in 8 of the cases. Exudative fluid was
acquired in 6 of the cases and among them, 5 cases had
bilateral effusions. None of the patients had chylous effu-
sions. All of these 6 cases also had high levels of serum
IgG. But only one of the cases underwent a pleural biopsy,
which showed unspecific chronic inflammation. High-
resolution chest CT in 14 of the cases with parenchymal
involvement showed lymphocytic interstitial pneumonia
(LIP)-like changes in 3 of the cases, multiple nodules of
different sizes and sites in 6 of the cases, multiple patchy
infiltrates in 6 of the cases, ground-glass opacities (GGO)
in 5 of the cases and consolidation in 3 cases (Figure 2).
Laboratory tests
Some of the test results are summarized in Table 1. All
48 cases had complete blood count results. In the UCD
group, there were 3 cases (18.8%) who had anemia, with
a mean hemoglobin of (133.13 ± 29.70) g/L. In the MCD
Figure 1 A 40-year-old woman was diagnosed with unicentric Castleman disease of hyaline vascular variant after thoracic surgery.
She was admitted to our hospital because of slight chest distress for 9 months. Contrasted chest CT showed a well-defined and homogeneous
enhanced mass in the right hilum, with coarse calcification (A-C). It was almost normal under the examination of bronscopy and the transbronchial
needle aspiration (TBNA) biopsy of the right hilar mass showed chronic inflammation. Whole resection of the mass was performed and prominent
diffuse proliferation of lymphoid cells with central hyalinized vascular structures was showed pathologically (D, Hematoxylin and eosin, ×200). she was
diagnosed with Castleman disease of hyaline vascular variant. Chemotherapy was not suggested. she had been alive without recurrence for 7 years.
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the mean hemoglobin was (108.66 ± 26.60)g/L. It seemed
like the MCD patients were prone to suffer from
anemia, but the difference was not statistically signi-
ficant. There was no difference in the platelet counts
between the UCD group and the MCD group.
Serum LDH level have been associated with the progno-
sis of some kinds of lymphoma [21]. We compared the
initial serum LDH level between these two groups and it
showed no difference. There were 5 cases in both groups
with elevated serum LDH (30% vs 16.1%, Z = 0.33,
P = 0.67). Hypoalbuminemia was more common in pa-
tients with MCD (25% vs 68.8%, Z = 8.22, P = 0.04). As
only 3 cases with UCD had been arranged with serum IgG
detection, the difference between them could not be com-
pared. In the MCD group, the serum IgG was tested in 27
cases, and the mean serum IgG was 29.5 g/l. Twenty of
the cases (74.1%) showed elevated serum IgG, with the
highest IgG found to be 133 g/l.It was reported that kinds of systemic connective
tissue disease could complicated by Castleman’s disease
[22]. Autoantibodies analysis, including antinuclear anti-
bodies, anti-extractable nuclear antigens (ENA) anti-
bodies, anti-neutrophil cytoplasmic antibodies (ANCA)
should be tested for them. As a retrospective study, the
results of autoantibodies were acquired in only 4cases
with UCD and 30cases with MCD. For these 4 UCD
cases, only one had positive ANA with homogeneous
pattern at 1:80 titer. For the enrolled 30 MCD cases,
5 cases had positive ANA, with speckled pattern (S),
nucleolar (N) or homogeneous pattern (H), ie, S1:160,
N1:40, H1:80,H1:320 and H1:320. None of our enrolled
48 cases complicated by a systemic connective tissue
disease.
Pathological features
All patients had a definite pathological diagnosis. Sur-
gery was arranged for all of the 16 cases in the UCD
Table 2 Chest CT manifestations of the enrolled 48 cases
Chest CT characters n/%
UCDs (n = 16)






Size (113.56 ± 81.31) cm3
[(20–336) cm3]
Punctate calcification in the mass 5/31.25%
Enhancement in the contrast-enhanced








MCDs (n = 32)
Lymphadenopathy
Location







Diffuse parenchymal lung disease 14/43.75%
Multiple nodules in different size 6/18.75%









ФTwo cases with UCDs had been arranged for thoracic MRI instead of the
controlled chest CT.
CT: computed tomography, LN: lymph node, GGO: ground-glass opacities,
LIP: lymphocytic interstitial pneumonia.
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with superficial lymph node biopsies, including cervical
(9/28.13%), axillary (6/18.75%) and supratrochlear lymphnodes (1/3.12%). Sixteen cases had at least two superfi-
cial lymph node biopsies. Eight cases (25%) were per-
formed with video-assisted thoracic surgery (VATS) for
biopsy of mediastinal lymph nodes or lung and one case
(3.12%) underwent surgery for biopsy of lymph nodes in
the retroperitoneal space. CT-guided percutaneous lung
biopsies were arranged for two cases (6.25%).
With respect to our intrathoracic respiratory CD
histological type, 24 cases (50%) were classified as the
HV variant and 19 cases (39.58%) were diagnosed with
thePC variant. The remaining 5 cases (10.42%) were
diagnosed with the mixed variant form. HV variants
were more common in the UCD group (75% vs 37.5%,
χ2 = 6.03, P = 0.049) (Table 1).
Treatment and prognosis
Four cases with MCD were lost to follow-up, and the
other cases were available with a mean follow-up time of
75.4 months.
All UCD cases had thoracic surgery for diagnosis and
treatment. None of the cases were treated with chemo-
therapy and all of them were alive.
In MCD group, none of the patients had therapeutic
surgery performed, butexploratory surgery for biopsy were
arranged for them to acquire pathological diagnosis.
Twenty-eight of the 32 cases with MCD were prescribed
chemotherapy: CHOP (cyclophosphamide, adriamycin,
vincristine and corticosteroid 20cases), COP (cyclophos-
phamide, vincristine and corticosteroid, 1case), R-CHOP
(rituximab and CHOP, 1 case), MP (melphala plus pre-
dnisone, 1 case), melphala plus thalidomide and prednis-
one (1 cases) and corticosteroids plus cyclophosphamide
(4 cases). For the remaining 4 MCD cases, 3 of the cases
were suggested for regular follow up because of mild
symptoms with steady medication for at least 3 years, and
the last one refused chemotherapy but complained of
superficial lymphadenopathy at multiple sites for 11 years
and exertional dyspnea for 2 years (Figure 2).
In MCD group, three cases (9.38%) died: one was
complicated by BO and paraneoplastic pemphigus (PNP)
and she died of respiratory failure, one had diffuse par-
enchymal lung disease and suffered from a severe lung
infection during the chemotherapy and died, and the
other was complicated by myocardial amyloidosis and
pulmonary hypertension. All of them were prescribed
chemotherapy. Four cases were lost to follow-up after
they were discharged from our hospital. Seven of the
cases were stable and 18 cases improved after discharge.
Discussion
Although CD could arise from any site where lymphoid
tissue is normally present, the chest was the most com-
mon place to develop CD [4-6]. There were several
studies which reported thoracic and/or pulmonary CD
Figure 2 A 34-year-old man was diagnosed with multicentric Castleman disease of plasma cell variant after 11 years. He was complained
of multiple superficial lymphadenopathy and intermittent low-grade fever for 11 years and exertional dyspnea for 4 months. His local multiple biopsies
showed lymph node reactive hyperplasia. Short-term prednisone and repeated kinds of antibiotics were prescribed for him but his symptoms recurred.
In our hospital, erythrocyte sedimentation rate (ESR) was 140 mm/h and IgG was 133 g/l, which was polycolonal. His high resolution chest CT showed
multiple cysts and nodules, consolidations, diffuse bronchovascular thickening (LIP-like images) and multiple hilar and mediastinal lymphadenopathy
(A-C). The fifth biopsy was tried in his left epitrochlear lymph nodes and the pathological photomicrographs showed marked interfollicular infiltration of
plasma cells [D (Hematoxylin and eosin, ×200) and E (CD138 staining, ×200)]. Then he was diagnosed with Castleman disease of plasma cell variant.
He and his families refused chemotherapy, but he showed up in the local clinic regularly.
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radiologic features, HIV-associated CD and/or the pul-
monary manifestations. Our study is the first of a larger
analysis to describe the characteristics of respiratory or
intrathoracic CD in a single tertiary-referral hospital.
As HIV antibody screening was not popular in our
hospital before the 21 century, HIV tests were notTable 3 Surgeries for the enrolled UCDs and MCDs
UCD (n = 16) MCD (n = 32)
Thoracic surgery
Open thoracic surgery 16/100% 0
VATSξ 1/16.67% 8/25%
Abdominal surgery 0 1/3.12%
Superficial LN biopsy 0 21/65.6%
Cervical LN 0 9/28.13%
Axillary LN 0 6/18.75%
Supratrochlear LN 0 1/3.12%
Percutaneous lung biopsy 0 2/6.25%
VATS: video-assisted thoracic surgery LN: Lymphonode.
ξOne case with UCD was performed VATS initially, then he was changed to
open thoracic surgery because of severe adhesion in the surgery field.available for 6 MCD cases. But all enrolled cases who
had HIV antibody screening had negative results. Those
without HIV tests were all admitted before 2000, and
HIV infection was not so popular in China before 21
century [26]. So, cases enrolled in our study might be
considered as a cohort of non-HIV CD.
Forty percent of the CD in our hospital was located
mainly in the thorax, which was less than in previous
studies [4,5]. In Kwon’s study, they included the patho-
logically diagnosed CD involving the thoracic cavity,
axilla, chest wall, and the lower neck as thoracic CD [6].
The involved location was not analyzed in Shin’s [19],
Dispenzieri’s [1], Robinson’s [27] and Waterston’s [28]
studies.
According to the involved lymph nodal station or
organ, CD was divided into two clinical subtypes, i.e
UCD and MCD. Most studies showed that UCD cases
were more prominent than MCD cases [6,19,20]. In
Dispenzieri’s study, 53% of cases were UCD [1]. But in
Kawabata’s study, MCD was more common than UCD
[29]. And Talat et al. reviewed CD cases reported before
September 2009, they found that UCD was more com-
mon than MCD in HIV-negative CD groups, but all
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MCD was more common than UCD. So, the prevalence
of different clinical subtypes might vary from different
medical centers. And the clinical classification also cor-
related well with histopathological variants, key clinical
features including age, symptoms, treatment strategy
and prognosis, and laboratory results, e.g., anemia and
serum immunoglobulin levels [1-3,19,29,30], so as our
48 cases with intrathoracic CD. When we compared
characteristics between different clinical subtypes of in-
trathoracic CD in our study, cases in the MCD group
were older than in the UCD group, which was consistent
with previous studies [19]. But our MCDs was younger
than Dossier’s HHV-8 related HIV-negative MCDs,
which was suggested to be considered a single clini-
copathological entity, regardless of HIV status [31]. As
HHV-8 associated tests were not tested for our cases, we
could not tell whether this difference was related to
HHV-8 infection or not. And there were no gender dis-
tribution differences between our UCDs and MCDs.
HV variant cases were more common in our UCD
subgroup. Our MCD cases were more symptomic and
appeared sicker, including more fever, hepatomegaly
and/or splenomegaly and hypoalbuminemia than UCD
cases. Our MCD cases showed a lower hemoglobin
trend. As there were only 3 UCD cases that had IgG re-
sults, we could not compare the IgG difference between
the two groups statistically. But 74.1% of the MCD cases
in our group who had Ig serum levels checked showed
hyperglobulinemia.
Mass in various locations [4-6,32-34], pleural effusion
[12,35], bronchiolitis [9,14,36] and diffuse lung shadows
[6,15,23,24] had been reported in cases with intratho-
racic CD. Although masses could be found in the hilum
[6], mediastinum [6,37-39], intercostal spaces [4,5,40],
pleura [12], chest wall [32,33], trachea [8,34], lungs
[6,41], et al., most of the reported masses were located
in the hilum or mediastinum, and there was only rare
case report(s) showing masses in other intrathoracic
places. There were no more than 20 reported cases
showing masses located in the chest wall [32,33]. No
more than 10 reported cases with masses in the inter-
costal spaces [4,5,40], pleura [12], trachea [8,34], lungs
[6,41] respectively. Masses could be seen in both of our
UCD and MCD cases. All of our intrathoracic UCD
showed solitary masses in the mediastinum, hilum,
pluera or lungs. As reported in other studies [4,6], surgi-
cal resection was performed for our UCD cases and all
of them were alive.
Although all of the MCD cases had lymphadenopathy in
the hilum and/or mediastinum, only 3 of them showed a
significant mass in the hilum and/or mediastinum. There
were no cases in our study which had a mass in the chest
wall, intercostal space or trachea.There were no systemic reviews showing CD cases
complicated by pleural effusions. Some rare case reports
and the analysis of HIV-infected CD cases showed uni-
lateral or bilateral effusions [12,23,24,35,42]. In the case
reports the effusion was exudative [12,35] or chylous
[42], but there was no effusion tests for HIV-infected
CD cases [23,24]. Lesions originating from or involving
the chest wall or pleura, impaired drainage of lymphatic
fluids because of the compression caused by CD mass or
lymphadenopathy, and/or hypoalbuminia could be the
causes of pleural effusions in CD cases. Effusion was
more common in MCD than in UCD: there were 13
cases (40.6%) with MCD and 2 cases (12.5%) with UCD
which were complicated by pleural effusions. Although
most of them had bilateral effusions, most of our MCD
showed exudative effusions according to Light’s criteria
[43]. Without pleural biopsy, we could not explain the
causes of effusion.
Follicular bronchiolitis and BO were the reported
bronchiolitis in CD cases [9,14,36]. Only Hwangbo et al.
reported follicular bronchiolitis in CD cases [14]. But
there were some other studies showing the LIP or LIP-like
changes in CD cases [6,23,24]. Follicular bronchiolitis and
LIP were considered to be on the same spectrum of the
disease and the distinction is based on the extent and dis-
tribution of the lymphocytic infiltration [14].
There was LIP-like changes in our MCD cases’ chest
CT scans. As there was no lung biopsy for these cases,
we could not diagnose them as LIP or follicular bron-
chiolitis. Most of the CD cases complicated with BO had
suffered from PNP [9,36], and the pathogenesis of com-
plicated PNP and BO was unknown. But the prognosis
of CD associated with PNP and BO was poor. Although
most of these cases had complete resection of their
masses and/or chemotherapy, most of them died of re-
spiratory failure. Our case with MCD associated PNP
and BO died 3 years after thoracic surgery.
Diffuse parenchymal abnormalities had been reviewed
by Johkoh et al. [15], Guihot et al. [23,24] and Kwon
et al. [6]. In Johkoh’s study [15], they analyzed 12 MCD
cases who had diffuse lung disease and 7 cases who
underwent surgery or transbronchial lung biopsy and
were diagnosed with lymphocytic interstitial pneumon-
itis (LIP). With similar finding in other chest CT images
of cases, LIP seemed to present as the pulmonary mani-
festations of MCD. Guihot et al. [23,24] reviewed pul-
monary involvements in HIV-infected CD. They found
diffuse bilateral interstitial pneumonia with broncho-
vascular thickening, septal thickening and subpleural no-
dules, GGO, and pulmonary consolidations in these cases,
without bronchial dilation and cysts. Most of them had a
MCD attack, ie, rapid onset and regression within a few
days and with a high frequency of relapse. But besides
LIP-like images, multiple nodules in different size and
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cases’ chest CT scans. On the other hand, some of them
had mild symptoms and were stable on medications, so
no other therapies were arranged for them. Most of them
were stable or improved after therapy.
Our retrospective study had several limitations: First,
all enrolled cases had a definite pathological diagnosis,
which could result in selection bias. Second, serum Ig
analysis was not detected for all enrolled cases, especially
for UCD cases. IgG subtype analysis had been performed
since 2012 and it was popular after 2013 in our hospital.
So, most cases had no initial results of IgG subtype ana-
lysis. Third, IgG4-related disease (IgG4-RD) and plasma
cell variant CD are especially difficult and often impos-
sible to distinguish based on pathological findings due to
their similarities. Serum IL-6 level and HHV-8- related
antigen, latency-associated nuclear antigen1, are diffe-
rential diagnostic factors between IgG4-RD and CD [29].
But all of our cases did not receive tests for HHV-8 and
serum interlukin-6 (IL-6) levels, as these items were not
carried out in our hospital during that period. Although
all of the enrolled cases had no obvious allergic history,
which is more common in IgG4-RD patients, some
IgG4-RD cases might be enrolled in our cohort. But
none of our enrolled cases was revised their diagnosis
with IgG4-RD till September 2014.
Conclusions
MCD was more common than UCD in the intrathoracic
CD cases in our hospital. Intrathoracic MCD was older
and more symptomic and presented sicker than UCD
cases. HV variant cases were more common in our UCD
subgroup. All of our UCD cases showed masses in vari-
ous intrathoracic locations and surgical resection was
performed for all of them and all of them were alive.
Masses, pleural effusions, BO, and diffuse pulmonary
shadows, including LIP-like images, multiple nodules of
different sizes and sites, patchy, GGO, and consolida-
tions were shown in our MCD cases. Most of MCD
cases were arranged with chemotherapy and their prog-
nosis were worse than UCD’s.
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